Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

doplasmic reticulum (ER) of tumor cells. This dual effect of the drug activates cell suicide, or apoptosis, in tumor cells, but because these drugs do not inhibit mTORC1 and induce little ER stress in normal cells, normal cells are left unharmed.
  • Bionovo published the results of its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation in the peer-reviewed journal, Molecular and Cellular Endocrinology. The results of this study demonstrate that tamoxifen inhibits the beneficial effects of ERb in the prevention of breast cancer cell proliferation. This suggests that there is a biological rationale for the development of ERb drugs for the treatment of breast cancer.
  • The Company announced the addition of Dr. Debu Tripathy, a leading researcher and clinician in the area of breast cancer, to its Medical Advisory Board. Dr. Tripathy is a Professor of Medicine at the Keck School of Medicine at the University of Southern California (USC) and Co-Leader of the Women's Cancer Program at USC Norris Comprehensive Cancer Center.

    • Third Quarter Results

    Total operating expenses for the three months ended September 30, 2009 were $3.9 million compared to $5.2 million for the same period in 2008 and $4.1 million for the second quarter of 2009. The decrease in year-over-year spending was primarily a result of a decrease in clinical activity and reduced employee headcount. Operating expenses in the third quarter of 2009 were primarily related to the Menerba manufacturing process development and commercial quality assurance procedures. Company management expects operating expenses to remain consistent through the fourth quarter at a burn rate of between $1 million and $1.5 million per month.

    The Company reported a net loss for the three months ended September 30, 2009 of $3.7 million, or $0.05 per share, compared with a net loss of $5.1 million, or $0.07 per share, for the same
    '/>"/>

    SOURCE Bionovo, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/25/2009)...andSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareI...nnovatorandprovideroflessinvasive,miniaturizedcirc...entofadvancedheartfailure,todayannouncedthatitissc...PiperJaffrayHealthCareConferenceat8:00amESTonWedne...ewYorkPalaceHotel,December1-2. ,, Alivewebcasto...
    (Date:11/24/2009)...4/PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmant...ident,wasactuallyfullyconsciousandawakeduringthatt...eDynaVoxEyeMaxwasfeaturedinthesegmenttoillustrateh...unlockcommunication. ,, WHEN:GoodMorningAmerica...avoxtech.com ,, WHO:RomHoubenswasanengineer...
    (Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
    Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 1Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 2Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 3Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 4Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 5Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 6Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 7PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 1PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 2PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 3PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference 14083 4Tianyin Pharmaceutical Co Inc Obtains GMP Certification for Its New Production Facility 14080 1Tianyin Pharmaceutical Co Inc Obtains GMP Certification for Its New Production Facility 14080 2Tianyin Pharmaceutical Co Inc Obtains GMP Certification for Its New Production Facility 14080 3
    ...ralia, May 29, 2007 /PRNewswire/ -- Phase II,resul... talks on,HyCAMP(TM) , Australian drug development...s with the US Food and Drug Administration (FDA),f... clinical trial,of its metastatic colorectal cance... randomized Phase II clinical trial in 80,patients...
    ..., 2007 /PRNewswire-USNewswire/ -- Evidence is,accu...oporosis,reports the June 2007 issue of Harvard W...ple ages 50 and over who regularly took,antidepres...rs,(SSRIs) had double the rate of fractures as peo...nts to depression itself as a source,of endocrine ...
    Other Medicine Technology:Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2
    (Date:11/25/2009)...hat mimicked parts of speech colored perception of...y News) -- People can "hear" not only with their e... , In fact, sensations on the skin designed to ...le decipher sounds better, the Canadian scientists...her we could use tactile information in this way,"...
    (Date:11/25/2009)...ordsSafely,ImproveCare ,, WASHINGTON,Nov.25/P...irs(VA)andKaiserPermanentetodayannouncedanexciting...,sheroes.VAandKaiserPermanentearelaunchingapilotpr...ionusingtheNationwideHealthInformationNetwork(NHIN..., "Theabilitytosharecriticalhealthinformationis...
    (Date:11/25/2009)...resstoImproveOverallOutcomesforLungCancer ,, ...LungCancerAlliance-California(LCA-CA)issuedits2ndA...nassessmentofprogressbeingmadeagainstthislethaldis...ancerAlliance(LCA),theonlynationalorganizationdedi...lelivingwithoratriskforlungcancer. ,, (Photo: h...
    (Date:11/25/2009)...in French . , , Montreal, November 25, 2009 ...marketplace, thanks to a new partnership between G...d Cognitive Sensing Inc. (CSI), a privately owned ..., which commercializes discoveries from the Univer...d CSI have announced the signature of a license ag...
    (Date:11/25/2009)...rial function plays in insulin production , ...hondrial damage causes people with type 2 diabetes...ould lead to new treatments, U.S. researchers say....ivity. , The researchers found that when insuli...nd to circulating insulin, it triggers a "molecula...
    Breaking Medicine News(10 mins):Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2
    ... Isilon Scale-out NAS to Store Public Database of ...s , , SEATTLE, April 27 Isilon(R) Systems (N...S, today announced that the Personal Genome Proj...omic data in personalized medicine. The PGP is usi...
    ...eping Up on Developments in the Long term Care Ins...mers and professionals with an interest in long te...nformation. Now they can do as the pros do: have t...ing & Operations for LTC Financial Partners LL...
    ...t has expanded its information section on lung can...ost comprehensive treatment resources available fo...rchable, easy-to-use database contains doctor prof...e mesothelioma specialists in their area. , ...
    ... nursing medical malpractice challenge by introduc...roduct RNReport card introduces standardized shift... organized in their day to day tasks.RNReport Card...ur patient information handy.,RNReport Card was co...
    ...Packard Children,s Hospital and the Stanford Unive...avel the cause of a deadly and mysterious bowel di...s. The findings could lead to a better understandi...isorder, necrotizing enterocolitis, or NEC, is see...
    ...al and state governments easier access to flu test...althDay News) -- U.S. health officials declared a ...swine flu outbreak, as the number of confirmed cas...hreat posed by the outbreak was worsening. But, th...
    Other Medicine News:Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 2Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 3Health News:Long Term Care Alerting Methods Revealed by Industry Leaders 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 3Health News:RN Sisters Bring Low-Tech Innovations to New Nurses and Nursing Students 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 3Health News:U.S. Declares Public Health Emergency in Response to Swine Flu 2Health News:U.S. Declares Public Health Emergency in Response to Swine Flu 3Health News:U.S. Declares Public Health Emergency in Response to Swine Flu 4Health News:U.S. Declares Public Health Emergency in Response to Swine Flu 5
    ...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
    ...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
    ...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
    ...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
    Medicine Products: